Early control architecture decisions impact a facility’s long-term capabilities.

Control Strategies for Single-Use Systems

Single-use technologies allowed drug manufacturers to adapt to pandemic challenges.

The Evolving Aseptic Processing Landscape

Help prevent contamination in each of seven facility zones.

Clean Factory Systems

Topic

Hari Narayanan, PhD, is product marketing manager at Thermo Fisher Scientific.

Articles

Fully automated enzyme analysis can ease a persistent bottleneck in biocatalyst development for bio/pharmaceutical applications.

Advancing Enzyme Analysis

Moderna’s agreement with the UK government includes 29 million COVID-19 vaccine doses for delivery in 2022 and 31 million doses for delivery in 2023.

60 Million Doses of the COVID-19 Vaccine is Added to Moderna’s Supply Agreement with the UK

 Washington Editor, jillwechsler7@gmail.com.

High price tags threaten to block patient access to potentially life-saving cures and treatments.

FDA Grapples with the Promise and Perils of Gene Therapy

Fujifilm’s center adds local support in Suzhou, China for cell culture media optimization.

Fujifilm Irvine Scientific Builds Bioprocessing Innovation and Collaboration Center in China

Sartorius is investing €100 million (US$113 million) between 2021 and 2025 to expand capacities for production, innovation, and storage at its French facilities in Aubagne, Cergy, and Lourdes.

Sartorius to Invest in Growing Operations in France

Sartorius will invest approximately €270 million (US$305 million) to expand its biopharmaceutical manufacturing activities in South Korea’s biopharm hub.

Sartorius Launches Expansion in South Korea with Mullti-Million Dollar Investment

Raymond P. Goodrich, PhD, is the founder of PhotonPharma, executive director of the infectious disease research center at Colorado State University, and professor for the department of microbiology, immunology, and pathology at Colorado State University.

Amanda Guth, DVM, PhD, is the chief scientific officer for PhotonPharma.

Jon Weston is the president and CEO of PhotonPharma.

Terry Opgenorth, PhD, is the executive in residence life sciences for CSU Ventures.

Gary Gordon, MD, PhD, is the president of Global Coalition for Adaptive Research.

Autologous tumor cells engineered for immune system stimulation can target unique metabolic, genomic, and phenotypic characteristics of cancer cells.

Formulating Autologous Therapies for Cancer

Jennifer Markarian is manufacturing editor of BioPharm International.

Isolators move into smaller-volume processes, including cell and gene therapy manufacturing.

Trends in Isolator Equipment

Defining expectations, such as GMPs, is paramount for sourcing the right biopharmaceutical raw materials.

Ensuring Quality When Sourcing Biopharmaceutical Raw Materials 

Feliza Mirasol is the science editor for 

Confounding signals pose challenges to analytical methods necessary for managing residual impurity removal in biotherapeutic manufacturing.

Manufacturing

Control Strategies for Single-Use Systems

The Evolving Aseptic Processing Landscape

Clean Factory Systems